Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis

JinSong Geng1, HaiNi Bao1, YaLan Chen1

  • 1Evidence-based Medicine Center, Medical School of Nantong University , Jiangsu, China.

Insights

Nucleos(t)ide analogues effectively treat chronic hepatitis B (CHB) by improving viral DNA levels and seroconversion markers. These treatments are safe, with no increased serious adverse events compared to placebo.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Chronic hepatitis B (CHB) is a significant global health concern, leading to severe liver disease.
  • Hepatitis B virus (HBV) infection necessitates effective therapeutic strategies to prevent cirrhosis and liver cancer.

Purpose of the Study:

  • To evaluate the efficacy and safety of nucleos(t)ide analogues for treating CHB.
  • To compare the effectiveness of different nucleos(t)ide analogues in managing CHB.

Main Methods:

  • Systematic literature search and meta-analyses, including direct comparison and network meta-analysis (NMA).
  • Inclusion of 36 randomized controlled trials (RCTs) comparing nucleos(t)ide analogues against placebo or each other.

Main Results:

  • Nucleos(t)ide analogues demonstrated efficacy in HBeAg seroconversion, HBeAg loss, and achieving undetectable HBV DNA compared to placebo.
  • Tenofovir showed the best performance for HBeAg loss and undetectable HBV DNA, while entecavir was potent for ALT normalization.
  • No significant increase in serious adverse events was observed with nucleos(t)ide analogues versus placebo.

Conclusions:

  • Nucleos(t)ide analogues are effective treatments for CHB, improving key virological and biochemical markers.
  • Further high-quality, long-term RCTs are recommended to solidify findings and guide clinical practice.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
137
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
382
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.0K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
387
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
603